Floatz logo

197 assets in Follicular Lymphoma

Therapeutic assets addressing Follicular Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tiragolumab
Follicular Lymphoma
Hoffmann-La RocheP1/2CCC (48)
Tiselizumab
Follicular Lymphoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (48)
Tucidinostat
Follicular Lymphoma
The First Affiliated Hospital of Xiamen UniversityP2CCC (48)
Zeprumetostat
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2CCC (48)
Aleta-001
Follicular Lymphoma
Cancer Research UKP1/2CC (47)
cd22 car-transduced t cells
Follicular Lymphoma
Essen BiotechP1/2CC (47)
crc01
Follicular Lymphoma
Curocell Inc.P1/2CC (47)
Fludeoxyglucose
Follicular Lymphoma
University of WashingtonP1/2CC (47)
Lacutoclax
Follicular Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P1/2CC (47)
Plerixafor
Follicular Lymphoma
Case Comprehensive Cancer CenterP1/2CC (47)
Rocbrutinib
Follicular Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P1/2CC (47)
Loncastuximab Tesirine
Follicular Lymphoma
Universität MünsterP2CC (46)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer
Follicular Lymphoma
Mayo ClinicP2CC (45)
Itraconazole
Follicular Lymphoma
Epizyme, Inc.P1CC (44)
Adi-001
Follicular Lymphoma
Adicet TherapeuticsP1CC (43)
Anti-Icos Monoclonal Antibody Medi-570
Follicular Lymphoma
National Cancer Institute (NCI)P1CC (43)
Autologous Baffr-Targeting Car T Cells
Follicular Lymphoma
Mayo ClinicP1CC (43)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells
Follicular Lymphoma
City of Hope Medical CenterP1CC (43)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes
Follicular Lymphoma
City of Hope Medical CenterP1CC (43)
Bgb-21447
Follicular Lymphoma
BeOne MedicinesP1CC (43)
c402-cd19-car
Follicular Lymphoma
Shanghai Exuma Biotechnology Ltd.P1CC (43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Follicular Lymphoma
Roswell Park Cancer InstituteP1CC (43)
Fluoropropyl-Trimethoprim
Follicular Lymphoma
University of PennsylvaniaP1CC (43)
Gf-Cart01
Follicular Lymphoma
GenomeFrontier Therapeutics TW Co., Ltd.P1CC (43)
Hucart19-Il18-Edhfr Cells
Follicular Lymphoma
University of PennsylvaniaP1CC (43)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer
Follicular Lymphoma
Northside Hospital, Inc.P1CC (43)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)
Follicular Lymphoma
Fred Hutchinson Cancer CenterP1CC (43)
Ltz-301
Follicular Lymphoma
LTZ Therapeutics, Inc.P1CC (43)
ly4152199 - iv
Follicular Lymphoma
Eli Lilly and CompanyP1CC (43)
P-Cd19Cd20-Allo1
Follicular Lymphoma
Poseida Therapeutics, Inc.P1CC (43)
Pevonedistat
Follicular Lymphoma
City of Hope Medical CenterP1CC (43)
q702
Follicular Lymphoma
Mayo ClinicP1CC (43)
Rimiducid
Follicular Lymphoma
Poseida Therapeutics, Inc.P1CC (43)
Sonrotoclax
Follicular Lymphoma
City of Hope Medical CenterP1CC (43)
Wztl002-1
Follicular Lymphoma
Malaghan Institute of Medical ResearchP1CC (43)
Bgb-16673
Follicular Lymphoma
BeiGeneP1/2CC (41)
bn301
Follicular Lymphoma
BioNova Pharmaceuticals (Shanghai) LTD.P1/2CC (41)
br1733
Follicular Lymphoma
Shanghai Blueray Biopharma Co., Ltd.P1/2CC (41)
Btk-In-24
Follicular Lymphoma
Nurix Therapeutics, Inc.P1CC (41)
cd19-ucart
Follicular Lymphoma
University Hospital HeidelbergP1/2CC (41)
ctx112
Follicular Lymphoma
CRISPR Therapeutics AGP1/2CC (41)
Cytokine-Treated Veto Cells
Follicular Lymphoma
M.D. Anderson Cancer CenterP1/2CC (41)
Enzalutamide
Follicular Lymphoma
PfizerP1CC (41)
eo2463
Follicular Lymphoma
EnteromeP1/2CC (41)
exs73565
Follicular Lymphoma
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1CC (41)
Fruquintinib
Follicular Lymphoma
Immunitas TherapeuticsP1/2CC (41)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Klrb1 (Killer Cell Lectin Like Receptor B1, Nkr-P1A, Natural Killer Cell Surface Protein P1A, Clec5B, Cd161)], Homo Sapiens Monoclonal Antibody; Gamma1 Heavy Chain Homo Sapiens (1-450) [Vh (Homo Sapiens Ighv3-23*01 (96.9%) -(Ighd) -Ighj4*01 (85.7%), Q120>R (113), Cdr-Imgt [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, G1V29 Ch2 A84.4 (Ch1 K120 (218) (122-219), Hinge 1-15 (220-234), Ch2 G1V29 Ch2 N84.4>A (301) (235-344), Ch3 D12 (360), L14 (362) (345-449), Chs K2>Del (450)) (122-450)], (224-214')-Disulfide With Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (94.7%) -Igkj4*01 (91.7%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (153'), V101 (191') (108'-214')]; Dimer (230-230'':233-233'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1 Lacking The Glutamine Synthetase (Gs-Ko) Gene, Non-Glycosylated
Follicular Lymphoma
Immunitas TherapeuticsP1/2CC (41)
Mevrometostat
Follicular Lymphoma
PfizerP1CC (41)
Vnx-101
Follicular Lymphoma
Vironexis Biotherapeutics Inc.P1/2CC (41)
Zelebrudomide
Follicular Lymphoma
Nurix Therapeutics, Inc.P1CC (41)
Showing 101 to 150 of 197 assets
PreviousPage 3 of 4Next